Orphalan Drug Patent Portfolio
Orphalan owns 1 orange book drug protected by 2 US patents Given below is the list of Orphalan's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10988436 | Crystalline form of triethylenetetramine tetrahydrochloride and its pharmaceutical use | 03 May, 2039 | Active |
| US11072577 | Crystalline form of triethylenetetramine tetrahydrochloride and its pharmaceutical use | 03 May, 2039 | Active |
Latest Legal Activities on Orphalan's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Orphalan.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Post Issue Communication - Certificate of Correction | 31 Aug, 2021 | US11072577 |
|
Email Notification
Critical
| 26 Aug, 2021 | US11072577 |
| Mail Certificate of Correction Memo | 25 Aug, 2021 | US11072577 |
| Certificate of Correction Memo | 24 Aug, 2021 | US11072577 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 27 Jul, 2021 | US11072577 |
|
Recordation of Patent Grant Mailed
Critical
| 27 Jul, 2021 | US11072577 |
|
Email Notification
Critical
| 08 Jul, 2021 | US11072577 |
|
Issue Notification Mailed
Critical
| 07 Jul, 2021 | US11072577 |
|
Email Notification
Critical
| 25 Jun, 2021 | US11072577 |
|
Application ready for PDX access by participating foreign offices
Critical
| 24 Jun, 2021 | US11072577 |
|
PG-Pub Issue Notification
Critical
| 24 Jun, 2021 | US11072577 |
| Dispatch to FDC | 23 Jun, 2021 | US11072577 |
|
Application Is Considered Ready for Issue
Critical
| 23 Jun, 2021 | US11072577 |
|
Issue Fee Payment Verified
Critical
| 21 Jun, 2021 | US11072577 |
|
Issue Fee Payment Received
Critical
| 21 Jun, 2021 | US11072577 |
Orphalan's Family Patents
Orphalan drugs have patent protection in a total of 16 countries. It's US patent count contributes only to 18.2% of its total global patent coverage. Click
below to unlock the full patent family tree.
Orphalan Drug List
Given below is the complete list of Orphalan's drugs and the patents protecting them.
1. Cuvrior
Cuvrior is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10988436 | Crystalline form of triethylenetetramine tetrahydrochloride and its pharmaceutical use |
03 May, 2039
(14 years from now)
| Active |
| US11072577 | Crystalline form of triethylenetetramine tetrahydrochloride and its pharmaceutical use |
03 May, 2039
(14 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Cuvrior's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List